Devicor Medical Products, Inc.
USPTO PatentsView assignee record - 181 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Devicor ranks #2,172 of 49,997 tracked US assignees by granted-patent volume, with 181 patents across 21 technology areas.
- #2,172
- of 49,997 US assignees by volume
- Top 20%
- by Innovation Score (46.8/100)
- 15.6
- avg claims per patent
- -44%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R2172 · US Corporation #2,172 · 181 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MID 181 grants
- TOP-DECILE #2,172/49,997
- PHOTO-FINISH Enphase Energy
- CPC-FOCUS A61B · 21 areas
- INNOV-PAR 46.8/100
- CLAIMS-RICH 15.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -44% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Enphase Energy, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Devicor’s 46.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Devicor
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Cygames · near
Cygames · near
47 score
- Devicor Medical… · this assignee
Devicor Medical… · this assignee
47 score
- dSPACE digital… · near
dSPACE digital… · near
47 score
- Impossible Foods · near
Impossible Foods · near
47 score
- OnPoint Medical · near
OnPoint Medical · near
47 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Devicor's Innovation Score is 46.8/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Devicor?
Each dot is one of Devicor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Devicor’s own 15.6 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Devicor's grants concentrate
Devicor Medical Products, Inc. is a focused PatentsView assignee: 21 CPC subclasses with 91.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (31 grants) versus a trough of 7 in 2023. By volume, Devicor sits between Pall Corporation and The Sherwin-Williams Company.
Devicor's three-year grant acceleration
From 2019–2021 to 2022–2024, Devicor Medical Products, Inc. moved from 56 to 28 grants (0.50x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,703. See the growth leaderboard.
Who files at Devicor's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Pall
Pall Corporation
182 patents
- TPK Touch Solutio…
TPK Touch Solutions (XIAMEN) Inc.
182 patents
- Toshiba Global Co…
Toshiba Global Commerce Solutions, Inc.
182 patents
- Zhejiang Geely Ho…
Zhejiang Geely Holding Group Co., Ltd.
182 patents
- Enphase Energy
Enphase Energy, Inc.
181 patents
- Mentor Acquisitio…
Mentor Acquisition One, LLC
181 patents
- Piaggio & C SPA
Piaggio & C. SPA
181 patents
- The Sherwin-willi…
The Sherwin-Williams Company
181 patents
- Devicor Medical P… ◀
Devicor Medical Products, Inc.
181 patents
What this shows Devicor holds 181 patents at rank #2,172, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Devicor
By rank, the assignees closest to #2,172 in granted patent volume.
- Pall Corporation #2,168 · 182 patents
- TPK Touch Solutions (XIAMEN) Inc. #2,169 · 182 patents
- Toshiba Global Commerce Solutions, Inc. #2,170 · 182 patents
- Zhejiang Geely Holding Group Co., Ltd. #2,171 · 182 patents
- Enphase Energy, Inc. #2,173 · 181 patents
- Mentor Acquisition One, LLC #2,174 · 181 patents
- Piaggio & C. SPA #2,175 · 181 patents
- The Sherwin-Williams Company #2,176 · 181 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Devicor's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Devicor, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Devicor ranks #111 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (47 here).
Similar claim depth
Nearest assignees by average claims per patent (15.6 here).
Devicor's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 18 | 9.9% |
| 2016 | 31 | 17.1% |
| 2017 | 23 | 12.7% |
| 2018 | 19 | 10.5% |
| 2019 | 21 | 11.6% |
| 2020 | 12 | 6.6% |
| 2021 | 23 | 12.7% |
| 2022 | 11 | 6.1% |
| 2023 | 7 | 3.9% |
| 2024 | 10 | 5.5% |
| 2025partial year | 6 | 3.3% |
Which technologies does Devicor Medical Products, Inc. patent most?
Top 15 of 21 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Devicor Medical Products, Inc.'s patent record in context - here's where to go next.
- Devicor Medical Products, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 91.7% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #2,172 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Devicor Medical Products, Inc. against Pall Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.